Captopril in cardioplegia and reperfusion: Protective effects on the ischemic heart

Annals of Thoracic Surgery

Volumn 63, Issue 3, 1997, Pages 627-633

  Gurevitch, Jacob ^a,b   Pevni, Dimitri ^a   Frolkis, Inna ^a   Matsa, Menachem ^a   Paz, Yosi ^a   Mohr, Raphael ^a   Yakirevich, Vladimir ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CAPTOPRIL;

ANIMAL EXPERIMENT; ARTICLE; CARDIOPLEGIA; HEART FAILURE; ISOLATED HEART; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

EID: 0030929831     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(96)00932-0     Document Type: Article

References (25)

1. The Consensus Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med 1987;316:1429-35.
2. Parker M, Lee WH, Yushak M, Medina N. Comparison of captopril and enalapril in patients with severe chronic heart failure. N Engl J Med 1986;315:847-53.
3. Pfeffer JM, Pfeffer MA, Braunwald E. Influence of chronic captopril therapy on the infarcted ventricle of the rat. Circ Res 1985;57:84-5.
4. Gay RG. Early and late effects of captopril treatment after large myocardial infarction in rats. J Am Coll Cardiol 1990;16: 967-7.
5. Sharpe N, Smith H, Murphy J, Greaves S, Hart S, Gamble G. Early prevention of left ventricular dysfunction after myocardial infarction with angiotensin-converting-enzyme inhibition. Lancet 1991;337:872-6.
6. Pfeffer MA, Braunwald E, Moye LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the Survival and Ventricular Enlargement Trial. N Engl J Med 1992; 327:669-77.
7. Schoemaker RG, Debets JJM, Stryker-Boudier HAJ, Smits JFM. Delayed but not immediate captopril therapy improves cardiac function in conscious rats, following myocardial infarction. J Mol Cell Cardiol 1991;23:187-97.
8. Lorgeril M, Ovize M, Delaye J, Renaud S. Importance of the flow perfusion deficit in the response to captopril in experimental myocardial infarction. J Cardiovasc Pharmacol 1992; 19:324-9.
9. Alam S, Rezkalla S, Frakas P, Turi ZG. Deleterious cardiac effects of captopril during acute myocardial ischemia in the dog. Cardiovasc Res 1992;26:232-6.
10. Arad M, Shotan A, Horowitz L, Klein R, Rabinovitz B. Effects of captopril on metabolic and hemodynamic alterations in global ischemia and reperfusion in the isolated working rat heart. J Cardiovasc Pharmacol 1992;19:319-23.
11. Westlin W, Mullane K. Does captopril attenuate reperfusion-induced myocardial dysfunction by scavenging free radicals? Circulation 1988;77(Suppl 1):30-9.
12. Engelman RM, Rousou JA, Iyengar J, Das DK. Captopril, an ACE inhibitor, for optimizing reperfusion after acute myocardial infarction. Ann Thorac Surg 1991;52:918-26.
13. Cosin J, Rivera M, Solaz J, Hernandiz A, Andreas F. Effects of captopril on regional segment motion during acute coronary occlusion. Clin Cardiol 1992;15:411-6.
14. Hearse DJ, Stewart DA, Braimbridge MV. Cellular protection during myocardial ischemia. Circulation 1976;54:193-202.
15. Neely JR, Liebermeister H, Battersby EJ, Morgan HE. Effects of pressure development on oxygen consumption by isolated rat hearts. Am J Physiol 1967;212:804-14.
16. Gurevitch J, Barak J, Hochhauser E, Paz Y, Yakirevich V. Aprotinin improves myocardial recovery following ischemia and reperfusion. J Thorac Cardiovasc Surg 1994;108:109-18.
17. Pi XJ, Chen X. Captopril and ramiprilat protect against free radical injury in dilated working rat hearts. J Mol Cell Cardiol 1989;21:1261-71.
18. De Graeff PA, van Gilst WH, Bel K, de Langen CDJ, Kingama JH, Wesseling H. Concentration-dependent protection by captopril against myocardial damage during ischemia and reperfusion in a closed chest pig model. J Cardiovasc Pharmacol 1987;9(Suppl 2):537-42.
19. Litwin SE, Raya TE, Warner A, Litwin CM, Goldman S. Effects of captopril on contractility after myocardial infarction: experimental observations. Am J Cardiol 1991;68:26D-34D.
20. Johnston CI, Clappison BH, Anderson WP, Yasujima M. Effects of angiotensin-converting enzyme inhibition on circulating and local kinin levels. Am J Cardiol 1982;49:1405-9.
21. Van Gilst WH, Van Wijngaarden J, Schltens E, de Graeff PA, de Langen CD, Wesseling H. Captopril-induced increase in coronary flow: an SH-dependent effect on arachidonic acid metabolism? J Cardiovasc Pharmacol 1987;9(Suppl 2):31-6.
22. Goldschmidt JE, Tallrida RJ. Pharmacological evidence that captopril possesses an endothelium-mediated component of vasodilation: effect of sulfhydryl groups on endothelium-derived relaxing factor. J Pharmacol Exp Ther 1991;257: 1136-45.
23. Clough DP, Collis MG, Conway J, Hatton R, Keddie JR. Interaction of angiotensin-converting enzyme inhibitors with the function of the sympathetic nervous system. Am J Cardiol 1982;49:1410-4.
24. Malik KV, Nasjletti A. Facilitation of adrenergic transmission by locally generated angiotensin II in rat mesenteric arteries. Circ Res 1976;38:26-30.
25. McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 1985;312:159-63.